Zhijie Yu
- Behavioral Neuroscience top 10%
- Pathology and Forensic Medicine top 10%
- Vitamin D Research Studies 2
-
- Ferroptosis and cancer prognosis 7
-
- Hepatocellular Carcinoma Treatment and Prognosis 6
-
- Cancer-related molecular mechanisms research 4
-
- interferon and immune responses 3
-
- Cholangiocarcinoma and Gallbladder Cancer Studies 3
-
- RNA modifications and cancer 3
-
- COVID-19 Clinical Research Studies 2
- Partner nations
- ChinaUnited KingdomUnited States
In The Last Decade
Zhijie Yu
33 papers receiving 682 citations
Peers
Comparison fields: 5 of 96
- Behavioral Neuroscience 54
- Biological Psychiatry 21
- Pathology and Forensic Medicine 131
- Experimental and Cognitive Psychology 91
- Public Health, Environmental and Occupational Health 174
Countries citing papers authored by Zhijie Yu
This map shows the geographic impact of Zhijie Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhijie Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhijie Yu more than expected).
Fields of papers citing papers by Zhijie Yu
This network shows the impact of papers produced by Zhijie Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhijie Yu. The network helps show where Zhijie Yu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Zhijie Yu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 4 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 1 | |
| 4 | 2025 | 1 | |
| 5 | 2024 | 2 | |
| 6 | 2024 | 4 | |
| 7 | 2024 | 4 | |
| 8 | 2024 | 0 | |
| 9 | 2023 | 5 | |
| 10 | 2023 | 4 | |
| 11 | 2023 | 2 | |
| 12 | 2022 | 22 | |
| 13 | 2022 | 7 | |
| 14 | 2022 | 11 | |
| 15 | 2021 | 17 | |
| 16 | 2021 | 2 | |
| 17 | 2020 | 16 | |
| 18 | 2018 | 26 | |
| 19 | 2009 | 89 | |
| 20 | 2009 | 126 |
About Zhijie Yu
Zhijie Yu is a scholar working on Hepatology, Cancer Research and Toxicology, having authored 35 papers that have together received 707 indexed citations. Recurring topics across this work include Ferroptosis and cancer prognosis (7 papers), Hepatocellular Carcinoma Treatment and Prognosis (6 papers), Cancer-related molecular mechanisms research (4 papers), interferon and immune responses (3 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (3 papers), RNA modifications and cancer (3 papers), Vitamin D Research Studies (2 papers) and COVID-19 Clinical Research Studies (2 papers). The work is most often cited by research in Behavioral Neuroscience (54 citations), Biological Psychiatry (21 citations) and Pathology and Forensic Medicine (131 citations). Zhijie Yu has collaborated with scholars based in China, United Kingdom and United States. Frequent co-authors include An Pan, Oscar H. Franco, Huaixing Li, Ling Lu, Xu Lin, Tony Dadd, Lin Xu, Zeyu Guo, Erkki Vartiainen and Huiguang Tian. Their work appears in journals such as PLoS ONE, PEDIATRICS and Oncogene.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.